Congress highlights
Highlights from meetings and congresses on endometriosis
At ASRM2017 it was apparent that true research progress will not happen until sub-groups (phenotypes) of endometriosis are identified.
Endometriosis sessions at ESHRE’s 33rd Annual Scientific Meeting were better attended than ever – and were all about finding the balance between medical and surgical therapies for the individual woman.
Packed endometriosis special interest group pre-congress course at ESHRE in Geneva.
When like-minded individuals come together with a selfless, common, goal to champion the cause, we can truly lead positive change in the field of endometriosis.
Efficacy and safety of two different doses of elagolix, a GnRH antagonist, presented at World Congress on Endometrosis.
Top ten research priorities in endometriosis presented at 13th World Congress on Endometriosis.
100-year-old fertility technique could reduce IVF cases in women with endometriosis.
Chair-elect of the ASRM Endometriosis Special Interest Group, Doctor Stacey Missmer, provides highlights from this year’s annual meeting. There is no size that fits all – think symptoms and think endometrium behaviour!
Study suggests that endometriosis in organs outside of the pelvis may be common and clinically unrecognised.
Increased risk of ovarian cancer observed in women who had no children following assisted reproductive technologies, and in women with endometriosis treated for infertility.